Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scienture Holdings (SCNX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Scienture Holdings (SCNX) over the last 13 years, with Q3 2025 value amounting to $355692.0.

  • Scienture Holdings' Cash & Equivalents fell 3857.88% to $355692.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $355692.0, marking a year-over-year decrease of 3857.88%. This contributed to the annual value of $308096.0 for FY2024, which is 10281.75% up from last year.
  • Scienture Holdings' Cash & Equivalents amounted to $355692.0 in Q3 2025, which was down 3857.88% from $15391.0 recorded in Q2 2025.
  • Over the past 5 years, Scienture Holdings' Cash & Equivalents peaked at $7.7 million during Q2 2024, and registered a low of $15391.0 during Q2 2025.
  • Over the past 5 years, Scienture Holdings' median Cash & Equivalents value was $1.0 million (recorded in 2022), while the average stood at $2.0 million.
  • As far as peak fluctuations go, Scienture Holdings' Cash & Equivalents skyrocketed by 160169.26% in 2024, and later plummeted by 9980.06% in 2025.
  • Scienture Holdings' Cash & Equivalents (Quarter) stood at $3.1 million in 2021, then plummeted by 64.94% to $1.1 million in 2022, then crashed by 86.13% to $151908.0 in 2023, then soared by 102.82% to $308096.0 in 2024, then rose by 15.45% to $355692.0 in 2025.
  • Its Cash & Equivalents stands at $355692.0 for Q3 2025, versus $15391.0 for Q2 2025 and $2.0 million for Q1 2025.